Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. This is
The body mass index is not going away, a new report suggests, but it could be demoted to just a first step in making a
SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration,
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There are just two days
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
After years of prodding, the National Institutes of Health has adopted a new policy requiring companies seeking licenses to sell medical products invented with government
Vas Narasimhan, chief executive officer of Novartis AG, speaks during a news conference in Tokyo, Japan. At the JP Morgan Healthcare Conference 2025, Narsimhan talked
A new federal report on alcohol’s health effects has found even moderate drinking — within the bounds of U.S. nutrition guidance — could carry health
Daiichi Sankyo has exclusive rights to further develop and commercialise gatipotuzumab as an antibody-drug conjugate (ADC). Image Credit: Photographer: Kentaro Takahashi/Bloomberg via Getty Images Daiichi
What You Should Know: – Abridge has finalized an enterprise-wide agreement with Mayo Clinic to implement the AI-powered clinical documentation platform, starting with approximately 2,000 clinicians who